Zobrazeno 1 - 10
of 361
pro vyhledávání: '"E. Modigliani"'
Publikováno v:
Clinical Hemorheology and Microcirculation. 4:401-408
Autor:
C. Lauret, R.H. Snider, Hélène Bihan, E. Nylen, Régis Cohen, K.L. Becker, E. Modigliani, J.L. Moretti, L. Vittaz
Publikováno v:
Thyroid. 13:819-822
The hormonal serum marker for the presence and course of patients with medullary thyroid cancer (MTC) is the mature calcitonin (CT) peptide. Other CALC-1 gene products such as the 116-amino acid polypeptide prohormone, procalcitonin, as well as its c
Autor:
S. Franc, P. Niccoli-Sire, R. Cohen, S. Bardet, B. Maes, A. Murat, A. Krivitzky, E. Modigliani, The French Medullary Study Group getc
Publikováno v:
Clinical Endocrinology. 55:403-409
BACKGROUND Medullary thyroid carcinoma is a rare tumour derived from the thyroid parafollicular calcitonin-secreting cells. Calcitonin is a very specific marker of this cancer that allows preoperative diagnosis. Serum calcitonin assay is particularly
Autor:
E. Modigliani
Publikováno v:
La Revue de Médecine Interne. 20:490-503
Resume Introduction Le cancer medullaire du corps thyroide est un cancer rare (5 a 10 % des cancers thyroidiens), qui suscite beaucoup d'interet dufait de la possibilite, dans 25 a 30 % des cas, de formes hereditaires, appelees neoplasies endocrinien
Autor:
Bernard Conte-Devolx, José-Marie Campos, J. C. Bigorgne, Olivier Chabre, L. Baldet, Pierre B. A. Lecomte, Arnaud Murat, N. Beressi, Brigitte Franc, E. Modigliani, Ph. Caron, Patricia Niccoli-Sire, J.P. Beressi, Régis Cohen, Jean-Louis Kraimps
Publikováno v:
Thyroid. 8:1039-1044
Clinical characteristics and prognosis of 80 patients (53 women and 27 men) with sporadic medullary thyroid carcinomas (MTC), less than 1 cm in size (micro-MTC), operated on between 1971 and 1996 are reported (73 total and 7 partial thyroidectomies).
Autor:
José-Marie Campos, Béatrice Maes, Philippe Dumontier, Martin Schlumberger, Laurence Leclerc, A Boneu, J. C. Bigorgne, Bernard Conte-Devolx, Bernard Corcuff, Isabelle Guilhem, Régis Cohen, E. Modigliani
Publikováno v:
Clinical Endocrinology. 48:265-273
Background Prognostic factors of sporadic or inherited medullary thyroid carcinoma (MTC) are still controversial and have been assessed in old and small series. A better knowledge of these factors would improve patient management. Objective To evalua
Autor:
J. Caron, Gilbert M. Lenoir, Pierre Jean Guillausseau, I Schuffenecker, Marie Virally-Monod, Olivier Chabre, Charis Eng, Vincent Rohmer, L Leclerc, C. Houdent, E. Modigliani, Richard M. Brohet, M. Schlumberger, David E. Goldgar, Bernard Conte-Devolx, A Boneu
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:487-491
Germline mutations of the RET proto-oncogene are responsible for multiple endocrine neoplasia type 2, including multiple endocrine type 2A (MEN 2A), type 2B (MEN 2B), and familial medullary thyroid carcinoma. The relationship between specific mutatio
Autor:
Bernard Conte-Devolx, Patricia Niccoli, N. Wion-Barbot, Jean-François Henry, Catherine De Micco, Philippe Caron, Jean-Pierre Saint Andre, J. C. Bigorgne, E. Modigliani
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:338-341
The aim of our study was to assess the ability of routine calcitonin (CT) measurement to improve the preoperative diagnosis of medullary thyroid carcinoma (MTC) in nodular thyroid diseases. We systematically determined basal CT in 1167 patients befor
Autor:
P. Chanson, X. Jeunemaitre, M. Talbot, D. Simpson, Emmanuel Gautherot, Annick Martin, Maria Luisa Brandi, Jp. Aubert, Catharina Larsson, F. Mantero, Cx. Zhang, David Wynford-Thomas, Claude Jaffiol, M. Boggild, Simona Mantovani, A.M. Masini, Eric Clauser, A. Angeli, Véronique Alvaro, Cristina Missale, G. Gunz, B. Fournes, A. Enjalbert, Olov Nilsson, I. Morange-Ramos, Charis Eng, B. Conte-Devolx, A. Courseaux, Eric Rouvier, A. Murat, Lars-Ove Farnebo, Alessandra Finardi, Filip Farnebo, G. Cadiot, P. Niccoli, B. Allolio, C. Beldjord, Massimo Giovanelli, Colette Auzan, P. Jaquet, P. Gaudray, Corinne Prévostel, Chiara Fiorentini, A. Ali, M. Giovagnetti, Pascal Meyer, R. Monier, B. Maes, Marco Losa, M. Terzolo, V. Aubert, Xavier Bertagna, Sandra Sigala, J.F. Hewy, W. Farrell, G. Arnaldi, M. Klein, A. Calender, J. Leclère, Jérôme Bertherat, Frederic Lenne, G. Osella, Patricia René, J. Bicknell, Andrea Lania, N. Porchet, Pf. Plouin, C. Gicquel, M.C. Béné, A. Barlier, Lois M. Mulligan, A. Boneu, L. Caccavelli, B. Caillou, Anna Spada, P. Rochefort, G. Opocher, G. Faure, Jacques Barbel, S. Giraud, Deborah J. Marsh, F. Michiels, Johannes Järhult, P. Rodien, Jacob Lagercrantz, Bin Tean Teh, J. Feunteun, G. Weryha, Dominique Joubert, M. Reincke, I. Schuffenecker, J.B. Corcuff, L. Mercken, Kerstin Sandelin, C. Dumont, M. Schlumberger, Y. Le Bouc, E. Modigliani, Yves de Keyzer, V. Pascal-Vigneron, Emilia Ballaré, Günther Weber, A.S. Bates, R.N. Clayton, I. Pellegrini-Bouiller, PierFranco Spano, N. Barbot, Gm. Lenoir
Publikováno v:
Hormone Research. 47:I-IV
Autor:
Arnaud Murat, I Schuffenecker, P Niccoli, N Barbot, A Boneu, JB Corcuff, Jf Henry, E. Modigliani, Bart Maes, Bernard Conte-Devolx
Publikováno v:
Hormone Research. 47:221-226
Multiple endocrine neoplasia type 2 (MEN-2) is an inherited multiglandular disease with age-related penetrance and variable expression. The prognosis of MEN-2 is linked to the carcinological evolution of medullary thyroid cancer (MTC), which depends